107 related articles for article (PubMed ID: 7826142)
21. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
22. Recombinant interferon-gamma in the treatment of systemic sclerosis.
Kahan A; Amor B; Menkes CJ; Strauch G
Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614
[TBL] [Abstract][Full Text] [Related]
23. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis.
Kawaguchi Y; Kitani A; Hara M; Harigai M; Hirose T; Suzuki K; Kawakami M; Hidaka T; Ishizuka T; Kawagoe M
J Rheumatol; 1992 Aug; 19(8):1195-201. PubMed ID: 1328634
[TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
25. IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls.
Antonelli A; Ferri C; Ferrari SM; Mancusi C; Colaci M; Sebastiani M; Fallahi P
Scand J Rheumatol; 2011 Nov; 40(6):453-6. PubMed ID: 21722069
[TBL] [Abstract][Full Text] [Related]
26. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
27. Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts.
Kikuchi K; Kadono T; Fujimoto M; Ihn H; Sato S; Takehara K
Dermatology; 1995; 190(2):104-8. PubMed ID: 7727830
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM
Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943
[TBL] [Abstract][Full Text] [Related]
29. Different roles of PKC and PKA in effect of interferon-gamma on proliferation and collagen synthesis of fibroblasts.
Zhang XF; Guo SZ; Lu KH; Li HY; Li XD; Zhang LX; Yang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1320-6. PubMed ID: 15456534
[TBL] [Abstract][Full Text] [Related]
30. Mitogenic effect of double-stranded RNA in human fibroblasts: role of autogenous interferon.
Vilcek J; Kohase M; Henriksen-DeStefano D
J Cell Physiol; 1987 Jan; 130(1):37-43. PubMed ID: 3805129
[TBL] [Abstract][Full Text] [Related]
31. Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.
LeRoy EC; Mercurio S; Sherer GK
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1286-90. PubMed ID: 6461858
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8).
Nanes MS; McKoy WM; Marx SJ
Endocrinology; 1989 Jan; 124(1):339-45. PubMed ID: 2491807
[TBL] [Abstract][Full Text] [Related]
34. The mitogenic effects of sera from psoriatic subjects on normal dermal fibroblasts: an absence of correlation with the clinical activity of psoriasis.
Laubscher TA; Harris N; Chalton DO
Br J Dermatol; 1991 Feb; 124(2):163-7. PubMed ID: 2003999
[TBL] [Abstract][Full Text] [Related]
35. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
36. Reduced mitogenic action of insulin evaluated as 3H-thymidine uptake in diabetic cultured fibroblasts.
Rotella CM; Zonefrati R; Toccafondi RS; D'Alessandro A
Horm Metab Res; 1981 Oct; 13(10):565-9. PubMed ID: 7028591
[TBL] [Abstract][Full Text] [Related]
37. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
[TBL] [Abstract][Full Text] [Related]
38. Platelets are mitogenic for periosteum-derived cells.
Gruber R; Karreth F; Frommlet F; Fischer MB; Watzek G
J Orthop Res; 2003 Sep; 21(5):941-8. PubMed ID: 12919885
[TBL] [Abstract][Full Text] [Related]
39. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma.
Tiggelman AM; Boers W; Linthorst C; Sala M; Chamuleau RA
J Hepatol; 1995 Sep; 23(3):307-17. PubMed ID: 8550995
[TBL] [Abstract][Full Text] [Related]
40. T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.
Alfinito F; Lamberti A; Capobianchi MR; Nigro M; De Rosa G; Tassone P; Turco MC; Dianzani F; Venuta S
Leukemia; 1994 Aug; 8(8):1294-300. PubMed ID: 8057665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
